Association of Body Mass Index and Parkinson Disease A Bidirectional Mendelian Randomization Study

C. Domenighetti, A. Puschmann, C. Hellberg, M. Sharma, A. Elbaz, COURAGE-PD Consortium

Research output: Contribution to journalArticlepeer-review

Abstract

Background and Objectives: The role of body mass index (BMI) in Parkinson disease (PD) is unclear. Based on the Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in PD (Courage-PD) consortium, we used 2-sample Mendelian randomization (MR) to replicate a previously reported inverse association of genetically predicted BMI with PD and investigated whether findings were robust in analyses addressing the potential for survival and incidence-prevalence biases. We also examined whether the BMI-PD relation is bidirectional by performing a reverse MR.MethodsWe used summary statistics from a genome-wide association study (GWAS) to extract the association of 501 single-nucleotide polymorphisms (SNPs) with BMI and from the Courage-PD and international Parkinson Disease Genomics Consortium (iPDGC) to estimate their association with PD. Analyses are based on participants of European ancestry. We used the inverse-weighted method to compute odds ratios (ORIVW per 4.8 kg/m2 [95% CI]) of PD and additional pleiotropy robust methods. We performed analyses stratified by age, disease duration, and sex. For reverse MR, we used SNPs associated with PD from 2 iPDGC GWAS to assess the effect of genetic liability toward PD on BMI.ResultsSummary statistics for BMI are based on 806,834 participants (54% women). Summary statistics for PD are based on 8,919 (40% women) cases and 7,600 (55% women) controls from Courage-PD, and 19,438 (38% women) cases and 24,388 (51% women) controls from iPDGC. In Courage-PD, we found an inverse association between genetically predicted BMI and PD (ORIVW 0.82 [0.70-0.97], p = 0.012) without evidence for pleiotropy. This association tended to be stronger in younger participants (≤67 years, ORIVW 0.71 [0.55-0.92]) and cases with shorter disease duration (≤7 years, ORIVW 0.75 [0.62-0.91]). In pooled Courage-PD + iPDGC analyses, the association was stronger in women (ORIVW 0.85 [0.74-0.99], p = 0.032) than men (ORIVW 0.92 [0.80-1.04], p = 0.18), but the interaction was not statistically significant (p-interaction = 0.48). In reverse MR, there was evidence for pleiotropy, but pleiotropy robust methods showed a significant inverse association.DiscussionUsing an independent data set (Courage-PD), we replicate an inverse association of genetically predicted BMI with PD, not explained by survival or incidence-prevalence biases. Moreover, reverse MR analyses support an inverse association between genetic liability toward PD and BMI, in favor of a bidirectional relation. © American Academy of Neurology.
Original languageEnglish
Article numbere209620
JournalNeurology
Volume103
Issue number3
DOIs
Publication statusPublished - 2024

Subject classification (UKÄ)

  • Neurology

Free keywords

  • Aged
  • Body Mass Index
  • Female
  • Genome-Wide Association Study
  • Humans
  • Male
  • Mendelian Randomization Analysis
  • Middle Aged
  • Parkinson Disease
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • high density lipoprotein cholesterol
  • low density lipoprotein cholesterol
  • triacylglycerol
  • uric acid
  • adult
  • alcohol consumption
  • anxiety
  • Article
  • body mass
  • depression
  • disease duration
  • female
  • gene frequency
  • genetic liability
  • genome-wide association study
  • human
  • international parkinson disease genomics consortium
  • logistic regression analysis
  • major clinical study
  • male
  • Mendelian randomization analysis
  • neurosis
  • Parkinson disease
  • pleiotropy
  • prevalence
  • risk factor
  • single nucleotide polymorphism
  • aged
  • epidemiology
  • genetics
  • middle aged

Fingerprint

Dive into the research topics of 'Association of Body Mass Index and Parkinson Disease A Bidirectional Mendelian Randomization Study'. Together they form a unique fingerprint.

Cite this